Search Results

There are 1285 results for: content related to: Blood Pressure and Heart Rate Effects, Weight Loss and Maintenance During Long-Term Phentermine Pharmacotherapy for Obesity

  1. Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist

    The Journal of Clinical Pharmacology

    Volume 49, Issue 10, October 2009, Pages: 1228–1238, Dr Carol Addy, Ms Patricia Jumes, Ms Kimberly Rosko, Dr Susie Li, Dr Hankun Li, Dr Andrea Maes, Dr Amy O. Johnson-Levonas, Dr Jeffrey Chodakewitz, Dr S. Aubrey Stoch and Dr John A. Wagner

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009341651

  2. Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 10, October 2010, Pages: 876–882, J. G. Kang, C.-Y. Park, J. H. Kang, Y.-W. Park and S. W. Park

    Article first published online : 26 MAY 2010, DOI: 10.1111/j.1463-1326.2010.01242.x

  3. Alterations in alcohol consumption, withdrawal seizures, and monoamine transmission in rats treated with phentermine and 5-hydroxy-L-tryptophan


    Volume 59, Issue 5, April 2006, Pages: 277–289, A.K. Halladay, G.C. Wagner, A. Sekowski, R.B. Rothman, M.H. Baumann and H. Fisher

    Article first published online : 13 JAN 2006, DOI: 10.1002/syn.20239

  4. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine


    Volume 38, Issue 4, 15 December 2000, Pages: 471–476, Brian T. Callahan, Jie Yuan and George A. Ricaurte

    Article first published online : 18 OCT 2000, DOI: 10.1002/1098-2396(20001215)38:4<471::AID-SYN12>3.0.CO;2-6

  5. You have free access to this content
    How Physician Obesity Specialists Use Drugs to Treat Obesity


    Volume 17, Issue 9, September 2009, Pages: 1730–1735, Ed J. Hendricks, Richard B. Rothman and Frank L. Greenway

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2009.69

  6. Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: Therapeutic implications


    Volume 36, Issue 2, May 2000, Pages: 102–113, M.H. Baumann, M.A. Ayestas, C.M. Dersch, A. Brockington, K.C. Rice and R.B. Rothman

    Article first published online : 31 MAR 2000, DOI: 10.1002/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#

  7. You have free access to this content
    Enhanced Weight Loss Following Coadministration of Pramlintide With Sibutramine or Phentermine in a Multicenter Trial


    Volume 18, Issue 9, September 2010, Pages: 1739–1746, Louis J. Aronne, Amy E. Halseth, Colleen M. Burns, Stephan Miller and Larry Z. Shen

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2009.478

  8. You have free access to this content
    Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies


    Volume 23, Issue S2, July 2015, Pages: S1–S26, Caroline M. Apovian, W. Timothy Garvey and Donna H. Ryan

    Article first published online : 7 JUL 2015, DOI: 10.1002/oby.21140

  9. You have full text access to this OnlineOpen article
    Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults


    Volume 21, Issue 11, November 2013, Pages: 2163–2171, Louis J. Aronne, Thomas A. Wadden, Craig Peterson, David Winslow, Sarah Odeh and Kishore M. Gadde

    Article first published online : 17 OCT 2013, DOI: 10.1002/oby.20584

  10. Neurochemical mechanisms of phentermine and fenfluramine: Therapeutic and adverse effects

    Drug Development Research

    Volume 51, Issue 2, October 2000, Pages: 52–65, Richard B. Rothman and Michael H. Baumann

    Article first published online : 15 DEC 2000, DOI: 10.1002/1098-2299(200010)51:2<52::AID-DDR2>3.0.CO;2-H

  11. Antiobesity Pharmacotherapy: New Drugs and Emerging Targets

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 1, January 2014, Pages: 53–66, GW Kim, JE Lin, ES Blomain and SA Waldman

    Article first published online : 19 DEC 2013, DOI: 10.1038/clpt.2013.204

  12. Is phentermine an inhibitor of monoamine oxidase? A critical appraisal


    Volume 32, Issue 2, May 1999, Pages: 141–145, Richard B. Rothman

    Article first published online : 17 SEP 2008, DOI: 10.1002/(SICI)1098-2396(199905)32:2<141::AID-SYN8>3.0.CO;2-R

  13. Noradrenergic Agents

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Donald G. Barceloux, Pages: 233–254, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch13

  14. Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats


    Volume 38, Issue 2, November 2000, Pages: 167–176, H.L. Rowley, S.A. Butler, M.R. Prow, S.G. Dykes, S. Aspley, I.C. Kilpatrick and D.J. Heal

    Article first published online : 18 SEP 2000, DOI: 10.1002/1098-2396(200011)38:2<167::AID-SYN8>3.0.CO;2-W

  15. You have full text access to this OnlineOpen article
    Current and emerging medications for overweight or obesity in people with comorbidities

    Diabetes, Obesity and Metabolism

    K. Fujioka

    Article first published online : 8 JUL 2015, DOI: 10.1111/dom.12502

  16. The metabolism and urinary excretion in man of phentermine, and the influence of N-methyl and p-chloro-substitution

    Journal of Pharmacy and Pharmacology

    Volume 23, Issue 4, April 1971, Pages: 288–294, A. H. BECKETT and L. G. BROOKES

    Article first published online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1971.tb08659.x

  17. Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine


    Volume 65, Issue 3, March 2002, Pages: 125–130, Kenneth Lyons Jones, Kathleen A. Johnson, Lyn M. Dick, Robert J. Felix, Kelly K. Kao and Christina D. Chambers

    Article first published online : 15 FEB 2002, DOI: 10.1002/tera.10023

  18. Long-term weight control study I (weeks 0 to 34)

    Clinical Pharmacology & Therapeutics

    Volume 51, Issue 5, May 1992, Pages: 586–594, Michael Weintraub, Pavur R Sundaresan, Manish Madan, Barbara Schuster, Andrew Balder, Louis Lasagna and Christopher Cox

    Article first published online : 18 MAY 1992, DOI: 10.1038/clpt.1992.69

  19. Effects of phentermine and pentobarbital on choice processes during multiple probability learning (MPL) and decision processes manipulated by pay-off conditions

    Human Psychopharmacology: Clinical and Experimental

    Volume 12, Issue 4, July/August 1997, Pages: 379–392, E. R. Volkerts, M. W. Van Laar, M. N. Verbaten, G. Mulder and R. A. A. Maes

    Article first published online : 7 JAN 1999, DOI: 10.1002/(SICI)1099-1077(199707/08)12:4<379::AID-HUP883>3.0.CO;2-6

  20. Information Selection and Signal Probability in Multisource Monitoring Under the Influence of Centrally Active Drugs: Phentermine Versus Pentobarbital

    Human Psychopharmacology: Clinical and Experimental

    Volume 11, Issue 5, September 1996, Pages: 405–414, E. R. VOLKERTS, M. W. VAN LAAR, M. N. VERBATEN, G. MULDER and R. A. A. MAES

    Article first published online : 6 MAY 1999, DOI: 10.1002/(SICI)1099-1077(199609)11:5<405::AID-HUP782>3.0.CO;2-N